850376C

18:1 (Δ9-Trans) PC

1,2-dielaidoyl-sn-glycero-3-phosphocholine, chloroform

• 同義詞: 1,2-di-(9E-octadecenoyl)-sn-glycero-3-phosphocholine; PC(18:1(9E)/18:1(9E))
• 經驗公式（希爾表示法）: C₄₄H₈₄NO₈P
• CAS號碼: 56782-46-8
• 分子量：: 786.11
• MDL號碼: MFCD00043215
• 分類程式碼代碼: 51191904
• NACRES: NA.25

屬性

• 化驗: >99% (TLC)
• 形狀: liquid
• 包裝: pkg of 1 × 2.5 mL (850376C-25mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 850376C
• 濃度: 10 mg/mL (850376C-25mg)
• 脂質類型: phospholipids; cardiolipins
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: [P](=O)([O-])(OCC[N+](C)(C)C)OCC(OC(=O)CCCCCCC\C=C\CCCCCCCC)COC(=O)CCCCCCC\C=C\CCCCCCCC
• InChI: 1S/C44H84NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h20-23,42H,6-19,24-41H2,1-5H3/b22-20+,23-21+
• InChI 密鑰: SNKAWJBJQDLSFF-DQPVQCHKSA-N

描述

一般說明

18:1 (Δ9-Trans) PC is a phosphoglycerolipid, which consists of two unsaturated acyl chains.

The list of Phosphatidylcholine products offered by Avanti is designed to provide compounds having a variety of physical properties. Products available include short chain (C3-C8 are water soluble and hygroscopic), saturated, multi-unsaturated and mixed acid PC′s. All of the products are purified by HPLC, and special precautions are taken to protect the products for oxidization and hydrolysis.

應用

18:1 (Δ9-Trans) PC is suitable for use as a synthetic lipid to study its effects on sarcoplasmic reticulum (SR) Ca²⁺-ATPase (SERCA) activity.

包裝

5 mL Clear Glass Sealed Ampule (850376C-25mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H302,H315,H319,H331,H336,H351,H361d,H372
• 防範說明: P202 - P301 + P312 - P302 + P352 - P304 + P340 + P311 - P305 + P351 + P338 - P308 + P313
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
• 標靶器官: Central nervous system, Liver,Kidney
• 水污染物質分類（WGK）: WGK 3